INNT
TOTAL INVALIDATION PROCESSED BY THE IB
02/18/2024
Back to search
Official data from USPTO
ONCIRE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
21
Latest update
02/18/2024
Trademark type
Word
Nice classes
5
Filing date
06/17/2016
Registration date
11/01/2016
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/12/2023
Last transaction
05/12/2023
Responsible office
United States Patent and Trademark Office
Status code
709
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
CH
Examiner
POLZER, NATALIE M
Law office
L80
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Novartis AG
Representatives
Novartis Pharma AG, Trademark Department
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for the prevention and treatment of diseases and disorders of the nervous systemthe immune systemthe cardiovascular systemthe metabolic systemthe endocrine systemthe respiratory systemthe musculo-skeletal system and the genitourinary system; pharmaceutical preparations for the prevention and treatment of inflammatory disorders; pharmaceutical preparations for use in dermatologyoncologyhematology and in tissue and organ transplantationin ophthalmology and for gastroenterological disorders; pharmaceutical preparations for the prevention and treatment of ocular disorders and diseases; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and the treatment of allergies; pharmaceutical preparations for the prevention and treatment of diseases and disorders caused by bacteriaautoimmune diseases and disorderskidney diseases and disordersdiabetes; antifungalanti-infectiveantiviral preparations and antibiotics
Publications
History of USPTO decisions and trademark events.
21 publications found
INTS
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
01/29/2024
INPC
INVALIDATION PROCESSED
01/29/2024
INTR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
01/12/2024
C71T
CANCELLED SECTION 71
05/12/2023
GPNX
NOTIFICATION PROCESSED BY IB
12/16/2016
FICS
FINAL DISPOSITION NOTICE SENT TO IB
12/01/2016
FIMP
FINAL DISPOSITION PROCESSED
12/01/2016
GPAR
GRANT OF PROTECTION CREATED, TO BE SENT TO IB
12/01/2016
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
11/25/2016
R.PR
REGISTERED-PRINCIPAL REGISTER
11/01/2016
PUBO
PUBLISHED FOR OPPOSITION
08/16/2016
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
08/10/2016
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
08/10/2016
NPUB
NOTICE OF PUBLICATION
07/27/2016
MAFR
APPLICATION FILING RECEIPT MAILED
07/15/2016
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/12/2016
DOCK
ASSIGNED TO EXAMINER
07/11/2016
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/11/2016
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
07/08/2016
SDRC
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
07/07/2016
Continuous trademark protection
Get notified about every new filing that threatens ONCIRE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.